(Q42510705)

1 November 2017

title

Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation (English)

1 reference

1 November 2017

0 references

long-term potentiation

1 reference

Blaine E Bisel

1

1 reference

1 November 2017

Kristen M Henkins

series ordinal

2

1 reference

1 November 2017

Karen D Parfitt

series ordinal

3

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

Annals of the New York Academy of Sciences

1 November 2017

published in

1 reference

1 November 2017

volume

1097

1 reference

1 November 2017

page(s)

58-63

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1379.020

1 November 2017

1 reference

Adenylate cyclase-mediated forms of neuronal plasticity in hippocampal area CA1 are reduced with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1379.020

A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1379.020

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1379.020

Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1379.020

Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1379.020

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1379.020

1 reference

1 November 2017

1 reference